Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Candesartan Cilexetil

Candesartan Cilexetil Drugs 1998 Nov; 56 (5): 847-869 ADIS DRUG EVALUATION 0012-6667/98/0011-0847/$23.00/0 © Adis International Limited. All rights reserved. A Review of its Use in Essential Hypertension Karen J. McClellan and Karen L. Goa Adis International Limited, Auckland, New Zealand Various sections of the manuscript reviewed by: J. Chalmers, Northern Medical Research Foundation, Royal North Shore Hospital, University of Sydney, St Leonards, New South Wales, Australia; B. Dahlöf, Gothenburg University, Östra University Hospital, Gothenburg, Sweden; W.H. Frishman, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA; M. Kawabata, Fourth Department of Internal Medicine, Shimane Medical University, Izumo, Shimane, Japan; P. Lund-Johansen, Department of Medicine, University of Bergen, Haukeland Hospital, Bergen, Norway; R.J. MacFadyen, Cardiac Unit, Raigmore Hospital, Inverness, Scotland; T. Ogihara, Department of Geriatric Medicine, Osaka University Medical School, Yamadaoka, Japan; J.G. Riddell, Department of Therapeutics and Pharmacology, The Whitla Medical Building, Queens University, Belfast, Northern Ireland; P. Trenkwalder, Starnberg Hospital, University of Munich, Starnberg, Germany. Data Selection Sources: Medical literature published in any language since 1966 on candesartan cilexetil, identified using AdisBase (a proprietary database of Adis International, Auckland, New Zealand), Medline and EMBASE. Additional references were identified from the reference lists of published articles. Bibliographical information, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drugs Springer Journals

Candesartan Cilexetil

Drugs , Volume 56 (5) – Oct 19, 2012

Loading next page...
 
/lp/springer-journals/candesartan-cilexetil-JVPV1dSqyV

References (83)

Publisher
Springer Journals
Copyright
Copyright © 1998 by Adis International Limited
Subject
Medicine & Public Health; Pharmacotherapy; Pharmacology/Toxicology; Internal Medicine
ISSN
0012-6667
eISSN
1179-1950
DOI
10.2165/00003495-199856050-00013
pmid
9829158
Publisher site
See Article on Publisher Site

Abstract

Drugs 1998 Nov; 56 (5): 847-869 ADIS DRUG EVALUATION 0012-6667/98/0011-0847/$23.00/0 © Adis International Limited. All rights reserved. A Review of its Use in Essential Hypertension Karen J. McClellan and Karen L. Goa Adis International Limited, Auckland, New Zealand Various sections of the manuscript reviewed by: J. Chalmers, Northern Medical Research Foundation, Royal North Shore Hospital, University of Sydney, St Leonards, New South Wales, Australia; B. Dahlöf, Gothenburg University, Östra University Hospital, Gothenburg, Sweden; W.H. Frishman, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA; M. Kawabata, Fourth Department of Internal Medicine, Shimane Medical University, Izumo, Shimane, Japan; P. Lund-Johansen, Department of Medicine, University of Bergen, Haukeland Hospital, Bergen, Norway; R.J. MacFadyen, Cardiac Unit, Raigmore Hospital, Inverness, Scotland; T. Ogihara, Department of Geriatric Medicine, Osaka University Medical School, Yamadaoka, Japan; J.G. Riddell, Department of Therapeutics and Pharmacology, The Whitla Medical Building, Queens University, Belfast, Northern Ireland; P. Trenkwalder, Starnberg Hospital, University of Munich, Starnberg, Germany. Data Selection Sources: Medical literature published in any language since 1966 on candesartan cilexetil, identified using AdisBase (a proprietary database of Adis International, Auckland, New Zealand), Medline and EMBASE. Additional references were identified from the reference lists of published articles. Bibliographical information,

Journal

DrugsSpringer Journals

Published: Oct 19, 2012

There are no references for this article.